Symposium | Reimagining Healthcare and Global Health in the Longevity Era

---

LIVEFACE-TO-FACEDHPAMA

Saturday, October 3, 2026, 8:30 AM - 2:00 PM, Weill Cornell Medicine-Qatar, Doha, Qatar

People are living longer than ever before, yet many of those additional years are accompanied by chronic disease, multimorbidity, disability, and rising healthcare needs. As populations age, healthcare and global health systems face growing challenges related to prevention, healthspan, workforce preparedness, healthcare delivery, and health policy. These trends are highlighting important gaps between traditional disease-focused models of care and the evolving needs of individuals and populations in the longevity era, which increasingly require approaches that promote healthspan, prevention, wellbeing, and healthy ageing. Reimagining Healthcare and Global Health in the Longevity Era symposium will explore healthcare blind spots in the changing healthcare landscape, including the rising burden of non-communicable diseases and multimorbidity, healthy ageing, prevention, lifestyle medicine, healthcare delivery and communication challenges, scientific wellness, artificial intelligence, and other emerging approaches to improving population health. Bringing together healthcare professionals, public health practitioners, policymakers, academics, and other stakeholders, the symposium will examine the role of health policy and cross-sector partnerships in addressing the factors that influence health and healthy longevity. Through expert presentations and discussion, participants will explore opportunities to strengthen healthcare delivery, translate evidence into practice and policy, and advance healthcare systems that support longer and healthier populations globally.

1. Analyze healthcare blind spots in the changing healthcare landscape.
2. Discuss strategies to improve healthcare and health policy through cross sector partnerships

ACCME Accreditation Statement  The Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians ACCME Credit Designation Statement The Weill Cornell Medicine-Qatar designates this live activity for a maximum of 3.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. DHP Accreditation Statement This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health’s Department of Healthcare Professions-Accreditation Section and is approved for a maximum of 3.50 hours. The scientific planning committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest.

Disclosure of Relationships/Content Validity 

It is the policy of Weill Cornell Medicine-Qatar to adhere to Ministry of Public Health’s Department of Healthcare Professions (DHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CME/CPD activities are intended to be evidence-based and free of commercial bias.

Scientific Planning Committee

Mark Dimon Santos, Raji Anand, Ravinder Mamtani, Salah Ahmed Abdalkarim Taha, Samaah Shams Chalil, Sandhya Vijayakumar, Sharika Agnes, Sohaila Cheema, Sunil Suresh Harikrishnan, Vinoop Viswanathan:

• Have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose.  

• Will not be discussing unlabeled/unapproved use of drugs or products.

Course Directors

Ravinder Mamtani, Sohaila Cheema:

• Have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose.  

• Will not be discussing unlabeled/unapproved use of drugs or products.

Course Faculty

Ravinder Mamtani, Sohaila Cheema, Javaid Sheikh, Hanan Abdul Rahim, Suryanarayanan Sethumadhavan:

• Have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose.  

• Will not be discussing unlabeled/unapproved use of drugs or products.  

Course Administrator

Samaah Shams Chalil:

• Has no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose. 

• Will not be discussing unlabeled/unapproved use of drugs or products. 

Evaluation

An evaluation will be conducted online post activity. All participants are required to complete the evaluation to receive a certificate. The evaluation allows us to assess the degree to which the activity met its objectives. It will also guide the planning of future activities and inform decisions about improving the educational program.

You are not logged in.

Please click the button below to login or create a new account before continuing.

Mitigation of Relevant Financial Relationships

Weill Cornell Medicine-Qatar adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.